Tirzepatide for $149 a Month: What’s Included — and Why It Costs Less Than You Think
If you’ve searched for tirzepatide pricing, you’ve seen the range: $300, $400, $500 a month from the big telehealth brands — or suspiciously cheap offers that lock you into 12-month commitments before you know if the medication even suits you. So when people find tirzepatide for $149 a month, the first question is always the same: what’s the catch?
Here’s the complete answer. No asterisks.
What $149/month actually includes at CoraDoc
- Compounded tirzepatide, doctor-prescribed. Prescribed by a licensed U.S. physician after reviewing your health profile — dispensed by state-licensed compounding pharmacy partners.
- Your free provider visit. The medical consultation costs $0 — always. It’s included with every program, not billed separately.
- Titrated dosing with no surprise charges. This is the one that surprises people. Your doctor increases your dose over time as your body adjusts — and every dose increase is included in the same $149/month. Many providers raise the price as your dose goes up. CoraDoc doesn’t.
- Free 2-day shipping and free supplies. Cold-chain shipping, syringes, alcohol wipes — included.
- Ongoing physician oversight. Dose adjustments, side-effect management, and check-ins with a real care team throughout your six-month program.
AFTER YOUR PROGRAM
When you reach your goal, the maintenance plan is a flat $199 — at any dosage. No dose-based price ladder, ever.
See if you qualify — the visit is free
A licensed U.S. physician reviews your health profile at no cost. Most patients are treated within 48 hours.
Why it costs less than the big brands — honestly
- Compounded, not branded. Branded tirzepatide (Mounjaro®, Zepbound®) carries brand-name pricing. Compounded tirzepatide is prepared by licensed compounding pharmacies, which is why the cost structure is fundamentally different. Compounded medications are not FDA-approved — they’re regulated through state pharmacy boards and, for 503B facilities, FDA registration and cGMP standards.
- No ad-bloat pricing. The $400+/month brands spend enormous amounts on Super Bowl ads and celebrity campaigns. That spend lives inside their price.
- One-time payments, no subscription machinery. CoraDoc doesn’t run auto-renewing subscriptions, so there’s no retention department, no cancellation friction, and no pricing games built around locking you in.
The comparison that matters
- vs. the $300–$500/mo brands: same category of physician-guided compounded programs — at a fraction of the monthly cost, with dose increases included.
- vs. the ultra-cheap 12-month lock-ins: some advertise lower monthly prices but require paying for a full year upfront or contractually committing before your body has ever tried the medication. CoraDoc’s program is six months with transparent one-time payments.
THE PRINCIPLE
You should know exactly what you’ll pay before you start, and the number shouldn’t climb as your dose does. That’s the entire pricing philosophy.
What CoraDoc programs include
Licensed physician oversight throughout your program · dosage adjustments as your body changes · ongoing care-team support by real humans · compounded semaglutide from $99/mo or compounded tirzepatide from $149/mo · free visit, free shipping, free supplies.
✓ Doctor-prescribed ✓ All 50 states ✓ LegitScript certified ✓ No subscription
Tirzepatide from $149/month — everything included
Free doctor visit · free 2-day shipping · free supplies · dose increases included · no subscription.
Compounded tirzepatide and semaglutide are not reviewed or approved by the FDA for safety, efficacy, or manufacturing quality and are not the same as branded medications. Prescriptions are issued only if a licensed provider determines a program is appropriate for you. Individual results vary. Mounjaro®, Zepbound®, Ozempic®, and Wegovy® are trademarks of their respective owners; CoraDoc is not affiliated with or endorsed by Eli Lilly or Novo Nordisk.
Educational only — not medical advice. This guide is for general information and is not a substitute for consultation with a licensed healthcare provider. It does not diagnose, treat, or guarantee any outcome. Statistics cited are approximate and drawn from published clinical literature.
Prescription products are dispensed only if a licensed provider determines they’re appropriate for you. Certain medications offered through CoraDoc are compounded and are not reviewed or approved by the FDA for safety, efficacy, or manufacturing quality. Semaglutide and tirzepatide are not for everyone; potential side effects should be discussed with a provider. Individual results vary.

